𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Milnacipran treatment of a terminally ill cancer patient with major depressive disorder

✍ Scribed by Kazuhiro Sato; Hisashi Higuchi; Keizo Yoshida; Hitoshi Takahashi; Tetsuo Shimizu; Jun Watanabe

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
36 KB
Volume
19
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of a brief screening intervi
Development of a brief screening interview for adjustment disorders and major depression in patients with cancer
✍ Nobuya Akizuki; Tatsuo Akechi; Tatsuro Nakanishi; Eisho Yoshikawa; Masako Okamur πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Adjustment disorders and major depression are common psychiatric disorders in patients with cancer and have a serious impact on quality of life. The problem in clinical oncology settings is underrecognition of these disorders; as a result, screening is recommended to dete

A double-blind dose-finding study of rol
A double-blind dose-finding study of rolipram in patients with major depressive disorder
✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 460 KB πŸ‘ 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re

A double-blind, multicenter trial compar
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co

How long should a trial of escitalopram
How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database
✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial

Effect of augmented atypical antipsychot
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting
✍ Ho-Jun Seo; Young-Eun Jung; Young Sup Woo; Tae-Youn Jun; Jeong-Ho Chae; Won-Myon πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

## Abstract ## Objective The extent of weight changes in depressed patients who use atypical antipsychotics (AAP) as augmentation could not be easily predicted due to weight related symptoms of depression and the interaction with antidepressants which have weight reducing effects. ## Methods Pat